Mohamad Tammam Elabiad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohamad Tammam Elabiad has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
- Ajay J. Talati
Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
4 shared publications - Ramasubbareddy Dhanireddy
Division of Neonatology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee
4 shared publications - Massroor Pourcyrous
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Tennessee Health Science Center, Regional One Health Hospital NICU, LeBonheur Children's Hospital NICU, Memphis, Tennessee, United States
3 shared publications Charles W. Leffler
Department of Pediatrics, University of Tennessee Health Science Center (UTHSC), Memphis, TN, USA
2 shared publicationsHelena Parfenova
Department of Physiology, University of Tennessee Health Science Center (UTHSC), Memphis, TN, USA
2 shared publicationsKristopher L. Arheart
Division of Biostatistics and Pediatrics, Department of Public Health Sciences, Miller School of Medicine University of Miami, Coral Gables, Florida
2 shared publications
Latest Publications
- Open Access
- 11 July 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (3) , 1213-1219
Association Between Hypochromic Microcytic Anemia in Pregnancy and Cord Blood Levels of Cadmium, Lead, Manganese, Mercury, and Selenium
Iron deficiency anemia (IDA) has been associated with increased blood lead (BPb). Increased BPb in pregnancy has been associated with increased cord BPb. The association between IDA in pregnancy and cord PB levels has not been previously investigated. It is thus hypothesized that IDA in pregnancy results in increased cord BPb levels. Prospectively, cord blood, from term infants delivered in Memphis, TN, was tested for lead, manganese, mercury, and selenium. Maternal charts were retrospectively reviewed and subjects enrolled into two groups: IDA group with hemoglobin < 9 g/dL, 65 fl < MCV 75 fl, MCHC < 32 g/dL and controls with hemoglobin > 12 g/dL, 80 fl < MCV < 95 fl and MCHC > 34 g/dL. Exclusion criteria were chronic conditions, sickle cell disease, and thalassemia. Fifty-five infants were included, with 27 in the maternal anemia group and 28 in the control group. There were no significant differences between groups in maternal age, pregnancy histories, prenatal vitamin and iron intakes, or other morbidities. Pregnancies with anemia had significantly lower BPb and blood mercury (BHg) levels and significantly higher blood selenium (BSe) levels than those without anemia,0.24 (0.18,0.32) µg/L, 0.19(0.17,0.52), 184 ± 31 vs 0.33 (0.27,0.45), 0.55 (0.27,0.92), 160 ± 33, respectively. Conclusion: Pregnancies with anemia were associated with significantly higher cord BSe levels and lower BPb and BHg levels than pregnancies without anemia. Selenium consumption has been shown to lower BPb and BHg levels. This may explain our findings. Future studies are needed to investigate the role of selenium consumption as a protective agent against the transfer of heavy metals across the placenta.
- 11 July 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (3) , 1213-1219
Open AccessAssociation Between Hypochromic Microcytic Anemia in Pregnancy and Cord Blood Levels of Cadmium, Lead, Manganese, Mercury, and Selenium
Iron deficiency anemia (IDA) has been associated with increased blood lead (BPb). Increased BPb in pregnancy has been associated with increased cord BPb. The association between IDA in pregnancy and cord PB levels has not been previously investigated. It is thus hypothesized that IDA in pregnancy results in increased cord BPb levels. Prospectively, cord blood, from term infants delivered in Memphis, TN, was tested for lead, manganese, mercury, and selenium. Maternal charts were retrospectively reviewed and subjects enrolled into two groups: IDA group with hemoglobin < 9 g/dL, 65 fl < MCV 75 fl, MCHC < 32 g/dL and controls with hemoglobin > 12 g/dL, 80 fl < MCV < 95 fl and MCHC > 34 g/dL. Exclusion criteria were chronic conditions, sickle cell disease, and thalassemia. Fifty-five infants were included, with 27 in the maternal anemia group and 28 in the control group. There were no significant differences between groups in maternal age, pregnancy histories, prenatal vitamin and iron intakes, or other morbidities. Pregnancies with anemia had significantly lower BPb and blood mercury (BHg) levels and significantly higher blood selenium (BSe) levels than those without anemia,0.24 (0.18,0.32) µg/L, 0.19(0.17,0.52), 184 ± 31 vs 0.33 (0.27,0.45), 0.55 (0.27,0.92), 160 ± 33, respectively. Conclusion: Pregnancies with anemia were associated with significantly higher cord BSe levels and lower BPb and BHg levels than pregnancies without anemia. Selenium consumption has been shown to lower BPb and BHg levels. This may explain our findings. Future studies are needed to investigate the role of selenium consumption as a protective agent against the transfer of heavy metals across the placenta.
- Open Access
- 3 June 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-7
Changes in urinary kidney injury molecule-1 levels after blood transfusions in preterm infants
Literature supports an association between transfusions and gut injury in preterm infants. We hypothesized that packed red blood (PRBC) transfusions are associated with kidney inflammation marked by a rise in urinary levels of Kidney Injury Molecule 1 (KIM-1). Prospectively, KIM-1 levels were measured before and then at 6, 12 and 24 h after a PRBC transfusion. Results are presented as mean (± SD) and median (IQR). Thirty-four infants, birth weight 865 (± 375) g, had higher pretransfusion KIM-1 levels of 2270 (830, 3250) pg/mg than what is normal for age. These were not associated with hematocrit levels. KIM-1 levels peaked between 6 and 12 h after the transfusion. Levels peaked to 3300 (1990, 6830) pg/mg; levels returned to pretransfusion levels of 2240 (1240, 3870) pg/mg by 24 h, p < 0.01. The 24-h post-transfusion KIM-1 levels were similar to pretransfusion levels, p = 0.63. PRBC transfusions in preterm infants are associated with an elevation in urinary KIM-1 levels. The mechanism of this association may be important in studying transfusion associated organ injury. KIM-1, as an inflammatory marker, may be helpful in assessing the effect of different transfusion volumes or in evaluating operational thresholds of anemia in premature infants.
- 3 June 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-7
Open AccessChanges in urinary kidney injury molecule-1 levels after blood transfusions in preterm infants
Literature supports an association between transfusions and gut injury in preterm infants. We hypothesized that packed red blood (PRBC) transfusions are associated with kidney inflammation marked by a rise in urinary levels of Kidney Injury Molecule 1 (KIM-1). Prospectively, KIM-1 levels were measured before and then at 6, 12 and 24 h after a PRBC transfusion. Results are presented as mean (± SD) and median (IQR). Thirty-four infants, birth weight 865 (± 375) g, had higher pretransfusion KIM-1 levels of 2270 (830, 3250) pg/mg than what is normal for age. These were not associated with hematocrit levels. KIM-1 levels peaked between 6 and 12 h after the transfusion. Levels peaked to 3300 (1990, 6830) pg/mg; levels returned to pretransfusion levels of 2240 (1240, 3870) pg/mg by 24 h, p < 0.01. The 24-h post-transfusion KIM-1 levels were similar to pretransfusion levels, p = 0.63. PRBC transfusions in preterm infants are associated with an elevation in urinary KIM-1 levels. The mechanism of this association may be important in studying transfusion associated organ injury. KIM-1, as an inflammatory marker, may be helpful in assessing the effect of different transfusion volumes or in evaluating operational thresholds of anemia in premature infants.
- 28 May 2018
- Published by Springer Nature in Pediatric Research
- Vol. 84 (2) , 290-295
Does prolonged severe hypercapnia interfere with normal cerebrovascular function in piglets?
Hypercapnia causes cerebral vasodilation and increased cerebral blood flow (CBF). During prolonged hypercapnia it is unknown whether cerebral vasodilation persists and whether cerebrovascular function is preserved. We investigated the effects of prolonged severe hypercapnia on pial arteriolar diameters (PAD) and cerebrovascular reactivity to vasodilators and vasoconstrictors. Piglets were anesthetized, intubated and ventilated. Closed cranial windows were implanted to measure PAD. Changes in PAD were documented during hypercapnia (PaCO2 75–80 mm Hg). Cerebrovascular reactivity was documented during normocapnia and at 30, 60, and 120 min of hypercapnia. Cerebral vasodilation to hypercapnia was sustained over 120 min. Cerebrovascular responses to vasodilators and vasoconstrictors were preserved during hypercapnia. During hypercapnia, vasodilatory responses to second vasodilators were similar to normocapnia, while exposure to vasoconstrictors caused significant vasoconstriction. Prolonged severe hypercapnia causes sustained vasodilation of pial arteriolar diameters indicative of hyperperfusion. During hypercapnia, cerebral vascular responses to vasodilators and vasoconstrictors were preserved, suggesting that cerebral vascular function remained intact. Of note, cerebral vessels during hypercapnia were capable of further dilation when exposed to additional cerebral vasodilators and, significant vasoconstriction when exposed to vasoconstrictors. Extrapolating these findings to infants, we suggest that severe hypercapnia should be avoided, because it could cause/increase cerebrovascular injury.
- 28 May 2018
- Published by Springer Nature in Pediatric Research
- Vol. 84 (2) , 290-295
Does prolonged severe hypercapnia interfere with normal cerebrovascular function in piglets?
Hypercapnia causes cerebral vasodilation and increased cerebral blood flow (CBF). During prolonged hypercapnia it is unknown whether cerebral vasodilation persists and whether cerebrovascular function is preserved. We investigated the effects of prolonged severe hypercapnia on pial arteriolar diameters (PAD) and cerebrovascular reactivity to vasodilators and vasoconstrictors. Piglets were anesthetized, intubated and ventilated. Closed cranial windows were implanted to measure PAD. Changes in PAD were documented during hypercapnia (PaCO2 75–80 mm Hg). Cerebrovascular reactivity was documented during normocapnia and at 30, 60, and 120 min of hypercapnia. Cerebral vasodilation to hypercapnia was sustained over 120 min. Cerebrovascular responses to vasodilators and vasoconstrictors were preserved during hypercapnia. During hypercapnia, vasodilatory responses to second vasodilators were similar to normocapnia, while exposure to vasoconstrictors caused significant vasoconstriction. Prolonged severe hypercapnia causes sustained vasodilation of pial arteriolar diameters indicative of hyperperfusion. During hypercapnia, cerebral vascular responses to vasodilators and vasoconstrictors were preserved, suggesting that cerebral vascular function remained intact. Of note, cerebral vessels during hypercapnia were capable of further dilation when exposed to additional cerebral vasodilators and, significant vasoconstriction when exposed to vasoconstrictors. Extrapolating these findings to infants, we suggest that severe hypercapnia should be avoided, because it could cause/increase cerebrovascular injury.
- 1 January 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 168, 23-29.e4
Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide
- 1 January 2016
- Published by Elsevier in The Journal of Pediatrics
- Vol. 168, 23-29.e4
Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide
- 15 October 2015
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 33 (04) , 370-377
Trends in Medication Use in Very Low-Birth-Weight Infants in a Level 3 NICU over 2 Decades
Objective This study aims to study the association between trends in medication utilization and survival in very low-birth-weight (VLBW) infants over a 22-year period. Study Design Medications received by VLBW infants were extracted retrospectively for the four periods 1990 to 1994, 1995 to 2000, 2001 to 2005, and 2006 to 2011 from our perinatal database and stratified by two birth weight groups: ≤ 1,000 g and 1,001 to 1,500 g. Result A total of 5,529 VLBW infants were reviewed. The majority of them were African American (78%), with an increasing proportion over time. The median number of medications per patient in all VLBW infants remained similar over time, 9 (5, 15). A cardiovascular group of medications was most commonly used, with a significant increase in the use of dobutamine and indomethacin. A significant trend toward an increasing number of infants without any antibiotic exposure was also noted. Survival steadily and significantly increased from 83 to 87%. Conclusion The trends of overall medication use remained the same in our neonatal intensive care unit (NICU) over the past 22 years. There was no association between medication utilization and survival. VLBW infants continue to receive a high number of medications in the NICU, including a variety of antibiotics.
- 15 October 2015
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 33 (04) , 370-377
Trends in Medication Use in Very Low-Birth-Weight Infants in a Level 3 NICU over 2 Decades
Objective This study aims to study the association between trends in medication utilization and survival in very low-birth-weight (VLBW) infants over a 22-year period. Study Design Medications received by VLBW infants were extracted retrospectively for the four periods 1990 to 1994, 1995 to 2000, 2001 to 2005, and 2006 to 2011 from our perinatal database and stratified by two birth weight groups: ≤ 1,000 g and 1,001 to 1,500 g. Result A total of 5,529 VLBW infants were reviewed. The majority of them were African American (78%), with an increasing proportion over time. The median number of medications per patient in all VLBW infants remained similar over time, 9 (5, 15). A cardiovascular group of medications was most commonly used, with a significant increase in the use of dobutamine and indomethacin. A significant trend toward an increasing number of infants without any antibiotic exposure was also noted. Survival steadily and significantly increased from 83 to 87%. Conclusion The trends of overall medication use remained the same in our neonatal intensive care unit (NICU) over the past 22 years. There was no association between medication utilization and survival. VLBW infants continue to receive a high number of medications in the NICU, including a variety of antibiotics.
- 12 June 2015
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 32 (13) , 1281-1286
Preterm Infants Can Mount Appropriate C-Reactive Protein Responses to Early Onset Sepsis
Objective This study aims to evaluate whether infants born at ≤ 32 weeks' gestational age (GA) can mount C-reactive protein (CRP) responses during early onset bacterial sepsis that are comparable to infants born at > 32 weeks' GA. Methods Retrospectively (2003–2012) infants with a positive bacterial culture during the first 72 hours of life were identified and grouped into two categories based on their GA: ≤ 32 weeks (group A) and > 32 weeks (group B). Results Group A included 25 and group B included 122 infants. Both groups responded similarly to sepsis with an increase in CRP (p = 0.59). Each group had a significant change in intragroup CRP levels over time (p < 0.0001). However, in both groups, the degree of this change was at the same rate over time (p = 0.74). Conclusion CRP responses to bacterial sepsis during the first 72 hours of life in infants born at ≤ 32 weeks' GA are comparable to infants born at > 32 weeks' GA.
- 12 June 2015
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 32 (13) , 1281-1286
Preterm Infants Can Mount Appropriate C-Reactive Protein Responses to Early Onset Sepsis
Objective This study aims to evaluate whether infants born at ≤ 32 weeks' gestational age (GA) can mount C-reactive protein (CRP) responses during early onset bacterial sepsis that are comparable to infants born at > 32 weeks' GA. Methods Retrospectively (2003–2012) infants with a positive bacterial culture during the first 72 hours of life were identified and grouped into two categories based on their GA: ≤ 32 weeks (group A) and > 32 weeks (group B). Results Group A included 25 and group B included 122 infants. Both groups responded similarly to sepsis with an increase in CRP (p = 0.59). Each group had a significant change in intragroup CRP levels over time (p < 0.0001). However, in both groups, the degree of this change was at the same rate over time (p = 0.74). Conclusion CRP responses to bacterial sepsis during the first 72 hours of life in infants born at ≤ 32 weeks' GA are comparable to infants born at > 32 weeks' GA.
- Open Access
- 24 March 2015
- Published by Wiley in Physiological Reports
- Vol. 3 (3) , e12345
Brain-derived circulating endothelial cells in peripheral blood of newborn infants with seizures: a potential biomarker for cerebrovascular injury
Neonatal seizures have been associated with cerebrovascular endothelial injury and neurological disabilities. In a piglet model, the long‐term loss of endothelial regulation of cerebral blood flow coincides with the surge of brain‐derived circulating endothelial cells (BCECs) in blood. We hypothesized that BCECs could serve as a noninvasive biomarker of cerebrovascular injury in neonates with seizures. In a prospective pilot feasibility study, we enrolled newborn infants with confirmed diagnoses of perinatal asphyxia and intraventricular hemorrhage (IVH); both are commonly associated with seizures. Infants without clinical evidence of cerebrovascular injuries were representative of the control group. BCECs were detected in the CD45‐negative fraction of peripheral blood mononuclear cells by coexpression of CD31 (common endothelial antigen) and GLUT1 (blood‐brain barrier antigen) via automated flow cytometry method. In Infants with asphyxia (n = 12) and those with IVH grade III/IV (n = 5), the BCEC levels were 9.9 ± 0.9% and 19.0 ± 2.0%, respectively. These levels were significantly higher than the control group (n = 27), 0.9 ± 0.2%, P < 0.001. BCECs in infants with cerebrovascular insults with documented clinical seizures (n = 10; 16.8 ± 1.3%) were significantly higher than infants with cerebrovascular insults with subclinical or no seizures (n = 7; 9.5 ± 1.2%); P < 0.001. BCEC levels decreased with seizure control. BCECs levels were elevated in infants with seizures caused by severe IVH and perinatal asphyxia. We suggest that monitoring BCEC levels in peripheral blood can potentially offer a biological marker that reflects cerebrovascular insult and recovery. Further studies with a larger number of patients are required to support these findings.
- 24 March 2015
- Published by Wiley in Physiological Reports
- Vol. 3 (3) , e12345
Open AccessBrain-derived circulating endothelial cells in peripheral blood of newborn infants with seizures: a potential biomarker for cerebrovascular injury
Neonatal seizures have been associated with cerebrovascular endothelial injury and neurological disabilities. In a piglet model, the long‐term loss of endothelial regulation of cerebral blood flow coincides with the surge of brain‐derived circulating endothelial cells (BCECs) in blood. We hypothesized that BCECs could serve as a noninvasive biomarker of cerebrovascular injury in neonates with seizures. In a prospective pilot feasibility study, we enrolled newborn infants with confirmed diagnoses of perinatal asphyxia and intraventricular hemorrhage (IVH); both are commonly associated with seizures. Infants without clinical evidence of cerebrovascular injuries were representative of the control group. BCECs were detected in the CD45‐negative fraction of peripheral blood mononuclear cells by coexpression of CD31 (common endothelial antigen) and GLUT1 (blood‐brain barrier antigen) via automated flow cytometry method. In Infants with asphyxia (n = 12) and those with IVH grade III/IV (n = 5), the BCEC levels were 9.9 ± 0.9% and 19.0 ± 2.0%, respectively. These levels were significantly higher than the control group (n = 27), 0.9 ± 0.2%, P < 0.001. BCECs in infants with cerebrovascular insults with documented clinical seizures (n = 10; 16.8 ± 1.3%) were significantly higher than infants with cerebrovascular insults with subclinical or no seizures (n = 7; 9.5 ± 1.2%); P < 0.001. BCEC levels decreased with seizure control. BCECs levels were elevated in infants with seizures caused by severe IVH and perinatal asphyxia. We suggest that monitoring BCEC levels in peripheral blood can potentially offer a biological marker that reflects cerebrovascular insult and recovery. Further studies with a larger number of patients are required to support these findings.
- 25 February 2014
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (10) , 851-854
Adjusting for Bias in C-Reactive Protein Levels When Using a Vitros Slide Method in Infants
Objective Low total serum protein levels may cause a positive bias on C-reactive protein (CRP) detected by the Vitros 250 Chemistry System (Ortho-Clinical Diagnostics, Inc., Johnson & Johnson Co., Raritan, NJ). Low total serum protein levels are observed in some infants. Our objective was to define a cutoff value for normal levels of CRP measured on the Vitros System that is comparable to the cutoff value of 1.0 mg/dL measured by rate nephelometry on a Beckman Array System (Beckman Instruments Inc., Fullerton, CA). Study Design CRP was prospectively measured on the same serum sample on Vitros and Beckman systems. Using a result of ≥1.0 as the “gold standard” definition of an abnormal CRP, measures of association were calculated. Results CRP was measured in 981 blood samples that were collected from 361 infants. A cutoff CRP level using the Vitros system at 1.5 mg/dL had the highest sensitivity and negative predictive value comparable to 1.0 mg/dL measured by nephelometry. By regression analysis, each increase by 1 mg/dL by nephelometry caused an increase by 1.5 mg/dL on the Vitros system (R2 = 0.94; p < 0.001; slope = 0.66; 95% confidence intervals, 0.65, 0.67). Conclusion In infants, when measuring CRP levels by Vitros CRP slide system, a normal reference level of 1.5 mg/dL instead of 1 mg/dL should be used.
- 25 February 2014
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (10) , 851-854
Adjusting for Bias in C-Reactive Protein Levels When Using a Vitros Slide Method in Infants
Objective Low total serum protein levels may cause a positive bias on C-reactive protein (CRP) detected by the Vitros 250 Chemistry System (Ortho-Clinical Diagnostics, Inc., Johnson & Johnson Co., Raritan, NJ). Low total serum protein levels are observed in some infants. Our objective was to define a cutoff value for normal levels of CRP measured on the Vitros System that is comparable to the cutoff value of 1.0 mg/dL measured by rate nephelometry on a Beckman Array System (Beckman Instruments Inc., Fullerton, CA). Study Design CRP was prospectively measured on the same serum sample on Vitros and Beckman systems. Using a result of ≥1.0 as the “gold standard” definition of an abnormal CRP, measures of association were calculated. Results CRP was measured in 981 blood samples that were collected from 361 infants. A cutoff CRP level using the Vitros system at 1.5 mg/dL had the highest sensitivity and negative predictive value comparable to 1.0 mg/dL measured by nephelometry. By regression analysis, each increase by 1 mg/dL by nephelometry caused an increase by 1.5 mg/dL on the Vitros system (R2 = 0.94; p < 0.001; slope = 0.66; 95% confidence intervals, 0.65, 0.67). Conclusion In infants, when measuring CRP levels by Vitros CRP slide system, a normal reference level of 1.5 mg/dL instead of 1 mg/dL should be used.
- 17 December 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (10) , 863-868
Changes in Premature Infant Mercury and Lead Blood Levels after Blood Transfusions
Objective To describe the blood level changes of mercury and lead after packed red blood cell (PRBC) transfusions in ≤ 750 g birth weight infants. Study Design Heavy metal blood levels were measured in infants in PRBC units on 1st, 4th, 5th, and 7th days (D1, D4, D5, and D7) of life and in urine on D1, D4, and D7. Results A total of 10 infants were enrolled with a mean birth weight of 632 ± 72 g. Out of which nine infants received one or more PRBC transfusions, with an average of 2.9 ± 2.5 transfusions per infant. Heavy metals were detected in all the transfusions. The average mercury level was 1.33 µg/L on D1 and 1.66 µg/L on D7, p > 0.05. The average lead level was 0.32 µg/dL on D1 and 0.56 µg/dL on D7, p > 0.05. Urinary mercury excretion increased in infants with no bowel movements. Urinary excretion of lead decreased over time as blood levels increased. Conclusions After receiving blood transfusions, the blood levels of mercury and lead were maintained at the end of the 1st week of life. As there is no evidence of a proportionate increase in excretory amounts of these heavy metals, there is a concern that they are retained and potentially exert toxic effects.
- 17 December 2013
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 31 (10) , 863-868
Changes in Premature Infant Mercury and Lead Blood Levels after Blood Transfusions
Objective To describe the blood level changes of mercury and lead after packed red blood cell (PRBC) transfusions in ≤ 750 g birth weight infants. Study Design Heavy metal blood levels were measured in infants in PRBC units on 1st, 4th, 5th, and 7th days (D1, D4, D5, and D7) of life and in urine on D1, D4, and D7. Results A total of 10 infants were enrolled with a mean birth weight of 632 ± 72 g. Out of which nine infants received one or more PRBC transfusions, with an average of 2.9 ± 2.5 transfusions per infant. Heavy metals were detected in all the transfusions. The average mercury level was 1.33 µg/L on D1 and 1.66 µg/L on D7, p > 0.05. The average lead level was 0.32 µg/dL on D1 and 0.56 µg/dL on D7, p > 0.05. Urinary mercury excretion increased in infants with no bowel movements. Urinary excretion of lead decreased over time as blood levels increased. Conclusions After receiving blood transfusions, the blood levels of mercury and lead were maintained at the end of the 1st week of life. As there is no evidence of a proportionate increase in excretory amounts of these heavy metals, there is a concern that they are retained and potentially exert toxic effects.
- Open Access
Effect of birth weight on the association between necrotising enterocolitis and red blood cell transfusions in ≤1500 g infants
Context Reports evaluating a possible association between necrotising enterocolitis (NEC) and blood transfusion have been predominantly case–control studies. As the possible associations of disease with any variable on which cases and controls have been matched cannot be explored, a cohort study would offer a solution to this problem. Objective Our objective was to evaluate the association between exposure to a packed red blood cell (PRBC) transfusion and development of NEC in a cohort where biases of matching are omitted. Design In a retrospective cohort, exposed infants were defined as those who received a transfusion and did not develop NEC or developed NEC within 48 h of the transfusion. All others were considered unexposed. Setting A single regional perinatal centre in Memphis, Tennessee, USA. Patients 3060 ≤1500 g birth weights (BW) were included. Outcome measures The relative risk of developing NEC after exposure to a PRBC transfusion was measured. Results 3060 infants were identified. 174 infants (5.7%) developed NEC; 116 of the 174 infants (67%) were exposed. NEC infants had a significantly lower BW (924 vs 1042 g) and required a longer stay on a ventilator (7 vs 2 days). Divided into groups, infants with BW ≤750 , 751–1000 , 1001–1250 g and 1251–1500 g (n=52, 51, 46 and 25, respectively) had a relative risk of 0.14, 0.46, 1.83 and 1.78 (pConclusions Exposure to transfusions was less likely associated with NEC in ≤1000 g infants and remained a risk factor in 1001–1500 infants. BW has to be factored in any study evaluating the association between PRBC transfusions and NEC.
Open AccessEffect of birth weight on the association between necrotising enterocolitis and red blood cell transfusions in ≤1500 g infants
Context Reports evaluating a possible association between necrotising enterocolitis (NEC) and blood transfusion have been predominantly case–control studies. As the possible associations of disease with any variable on which cases and controls have been matched cannot be explored, a cohort study would offer a solution to this problem. Objective Our objective was to evaluate the association between exposure to a packed red blood cell (PRBC) transfusion and development of NEC in a cohort where biases of matching are omitted. Design In a retrospective cohort, exposed infants were defined as those who received a transfusion and did not develop NEC or developed NEC within 48 h of the transfusion. All others were considered unexposed. Setting A single regional perinatal centre in Memphis, Tennessee, USA. Patients 3060 ≤1500 g birth weights (BW) were included. Outcome measures The relative risk of developing NEC after exposure to a PRBC transfusion was measured. Results 3060 infants were identified. 174 infants (5.7%) developed NEC; 116 of the 174 infants (67%) were exposed. NEC infants had a significantly lower BW (924 vs 1042 g) and required a longer stay on a ventilator (7 vs 2 days). Divided into groups, infants with BW ≤750 , 751–1000 , 1001–1250 g and 1251–1500 g (n=52, 51, 46 and 25, respectively) had a relative risk of 0.14, 0.46, 1.83 and 1.78 (pConclusions Exposure to transfusions was less likely associated with NEC in ≤1000 g infants and remained a risk factor in 1001–1500 infants. BW has to be factored in any study evaluating the association between PRBC transfusions and NEC.